Khaitan & Co and Anderson, Mori & Tomotsune advised Japan’s Meiji Seika Pharma in buying Bangalore pharma company Medreich for Rs 1720 crore ($290m). Medreich was advised by Amarchand Mangaldas.
Khaitan corporate partner Bhavik Narsana, banking and finance partner Kumar Saurabh Singh, competition law partner Avaantika Kakkar, intellectual property partner Adheesh Nargolkar, real estate partner Abhishek Sharma and regulatory partner Sharad Vaid and Anderson Mori partners Yuichiro Nukada and Ryo Okochi acted for Meija.
Amarchand corporate partner Ashish Jejurkar and tax partner SR Patnaik acted for Medreich.
The buyout leads to the exit of the Singapore government’s investment arm Temasek which had invested Rs 109 crore in Medreich for a 25 per cent stake in 2005, reported Mint.
Amarchand, along with Luthra & Luthra, had also advised debt-ridden pharma giant Ranbaxy in being sold off to Sun Pharma two months ago.
threads most popular
thread most upvoted
comment newest
first oldest
first
to give khaitan its due, they did report the names of all partners who contributed to the deal.
Me thinks, not...
KCO is just keeping their folks busy as opposed to they being idle...
there name should also be given as international firms do name all the people involved in the deal.
What is the need to add this last line? Kian?? Trying to stir up something are we?
Thank you for your comment. This deal and the Sun Pharma deal are both big Japanese pharma transactions this quarter, and Amarchand was on both.
Yes I was therefore definitely interested in 'stirring up' that link :)
Best wishes,
Prachi
Country - Japan
Sector - Pharmacueticals
Practice - M&A (and FDI)
Law Firm - Amarchand & Mangaldas....
How do I see comments which are hidden due to down voting on iPad. Can't really hover! Even though no reply may be necessary! I am curious to see what was it that many people did not like!!
threads most popular
thread most upvoted
comment newest
first oldest
first